Piver M S
J Surg Oncol. 1979 Dec;12(4):365-70. doi: 10.1002/jso.2930120411.
In women with gynecologic malignancies the para-aortic lymph nodes are not routinely treated. However, pretherapy surgical staging has now disclosed an incidence of para-aortic node metastasis of 10.3% for presumed stage I and II ovarian cancer, 8.0% for stage I endometrial carcinoma, and 23.5% for stage II, III, and IV cervical cancer. Prospective trials to evaluate therapy directed to the para-aortic nodes in women with early ovarian and endometrial carcinoma have not been carried out. Moreover, the results of high dose irradiation to biopsy proven metastasis to the aortic lymph nodes from cervical cancer has resulted in only 11.9% survival without recurrence at two years.
在患有妇科恶性肿瘤的女性中，腹主动脉旁淋巴结通常不进行治疗。然而，目前的术前手术分期显示，对于假定的Ⅰ期和Ⅱ期卵巢癌，腹主动脉旁淋巴结转移的发生率为10.3%；对于Ⅰ期子宫内膜癌，发生率为8.0%；对于Ⅱ期、Ⅲ期和Ⅳ期宫颈癌，发生率为23.5%。尚未开展针对早期卵巢癌和子宫内膜癌女性患者腹主动脉旁淋巴结的评估治疗的前瞻性试验。此外，对经活检证实为宫颈癌腹主动脉旁淋巴结转移进行高剂量放疗的结果显示，两年时无复发的生存率仅为11.9%。
